Mirza MR, Bjorge L, Marme F, Christensen RD, et al. Palbociclib plus letrozole in estrogen receptor-positive advanced/recurrent endometrial cancer: Double-blind placebo-controlled randomized phase II ENGOT-EN3/PALEO trial. Gynecol Oncol 2024;192:128-136.
PMID: 39657575